kanamycin a has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arriagada-Vera, V; Campusano, JM; Diez, B; Guerra-Ayala, S; Hidalgo, S; Molina-Mateo, D; Oliva, C; Soto-González, A; Tamayo-Leiva, J; Valderrama, BP; Zárate, RV | 1 |
| Hasegawa, Y; Kobayashi, Y; Morishita, T; Tamatani, S; Tomioka, H | 1 |
2 other study(ies) available for kanamycin a and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations.
Topics: Animals; Anti-Bacterial Agents; Drosophila; Kanamycin; Parkinson Disease; Protein Kinases | 2023 |
[Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
Topics: Aged; Amikacin; Aorta, Thoracic; Aortic Aneurysm; Cephaloridine; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Parkinson Disease; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Subarachnoid Hemorrhage | 1975 |